Proton therapy for prostate cancer
|
|
- Domenic Grant
- 6 years ago
- Views:
Transcription
1 Proton therapy for prostate cancer Shafak Aluwini Radiation oncologist UMCG Protons versus photons Superior beam properties Advantage of protons 160 Photons Spread out Bragg Peak Tumor MV photons Protons Bragg Peak Organ at risk Skin Depth (cm) 30 1
2 Photons vs protons bundles 1 bundle 2 bundles 4 bundles Protons Photons Protons therapy technique Passive scattering technique Most used so far Pencil beam scanning technique (PBS) or spot scanning technique New facilities 2
3 Proton techniques Passive scattering Scattering Spread Out Bragg Peak Protonenbundel Proton techniques Pencil Beam Scanning (PBS) Magnets advantages: Less secondary neutrons Superior dose distribution 3
4 Uncertainties in Proton Therapy 1. The potential effects of calculation uncertainties 2. The potential effects of motion based uncertainties R hom Soft tissue bone R hom Soft tissue Setup error Soft tissue Underdosed area AJ Lomax, Phys. Med. Biol. 53 (2008) ,
5 IMPT Planning Techniques The lateral dose distribution is determined by the placement and weights of the spots on each energy layer. Spot weights are optimized for each beam direction using inverse planning techniques => beam weight maps for different energy layers. Kirk & Both, Penn Course 2014 Treatment Planning It is common for Inverse planning to require that any margins for set-up or range be incorporated into a structure which can be used to optimize the dose distribution. Standard PTV Additional margin for range uncertainty Beam 1 Beam 2 Kirk & Both, Penn Course
6 Photons vs Protons Dose reduction in several organs Photons Protons Intestine Intestine Widesot et al, Int J Radiat Oncol Biol Phys 2011 Prostate RT sparing rectum and bladder VMAT IMPT IMPT VMAT Virtueel Protonen Centrum GPTC - November
7 Prostate N+ sparing intestine VMAT IMPT VMAT IMPT Virtueel Protonen Centrum GPTC - November 2016 Bundles characteristics translated to patient advantage Tumor control Complications Probability (%) Improvement local control Prevention of complications 10 0 Current photons standard (IMRT photons) Complications Local tumour control Protons 7
8 Horizon Scanning Report Report of the Dutch Health Council (2009) 0% 10% 20% 30% 40% 50% 60% 70% Preventie Prevention ongewenste of neveneffecten complications 4,824 Verbetering Target dose lokale escalation controle Prevention Preventie van secundaire secondary tumoren tumours Standaardindicaties Standard indications ,215 Total number with expected benefit: 7,098 patients per year (based on Cancer Registry in 2005) Advice: Keep initial capacity below 4,000 patients per year Indications for proton therapy (4 categories) Proton therapy licenses (2013) Planned capacity: 2,200 patients per year Groningen (GPTC) Treatment rooms: 2 Capacity: 600 patients Vendor: IBA Operational: Q Amsterdam (APTC) Treatment rooms: 3 Capacity: 600 patients Status: On hold Delft (HollandPTC) Treatment rooms: 3 Capacity: 600 patients Vendor: Varian Operational: Q Maastricht (ZonPTC) Treatment rooms: 1 gantry Capacity: 400 patients Vendor: Mevion Operational: Q
9 Planned capacity In relation to total number of RT treatments Number per year Number of photon therapy treatment per year Assumed ramp up of 30%-60%-90%-100% % 0.8% 1.9% 2.8% 3.3% 3.4% Evidence-based medicine Gold standard RCT (Randomised Controlled Trial) Randomisation Standard treatment e.g. IMRT (photons) Experimental treatment e.g. IMPT (protons) Standard for introducing new curative methods with unpredictable outcome Not standard for introducing new technology with predictable outcome 9
10 Royal Dutch Academy of Arts and Sciences Most important scientific body in the Netherlands RCT s mostly not suitable / feasible for testing new technologies Alternative evidencebased methods needed and available No standard solution for all technologies But if we still need an RCT? 0 Individual patients -5 NTCP (%) Patients that would not benefit Patients that would benefit -25 Say, we include all patients. If the study is Negative Don t treat any patient with protons Not fair to the patients that would benefit Positive Treat all patients with protons Not efficient 10
11 Insurance report (2011) p. 6 NVRO consensus (2015) Thresholds for NTCP Thresholds for 1 complication CTCAE Grade I II 10% III 5% IV-V 2% Threshold for NTCP No indication NOTE: Special rules in case of multiple complications 11
12 What should we spare? It is impossible to spare all organs and tissues associated with toxicities We need to find the right priorities and even better, the right balance This depends on The impact of toxicity on quality of life Dose limits to avoid severe complications The relation between dose and complication probability We need NTCP models! Model-based approach 4 steps Selection STEP 1: NTCP model Multivariable NTCP-models, which patients have high risk op complications STEP 2: Individual dose comparison Dose reduction with protons? ( Dose): relevant DVH parameters STEP 3: Estimate NTCP reduction ( NTCP) Translate Dose to NTCP STEP 4: Validation and selection Validation External validation NTCP-model with new technology Langendijk, et al. Radiother Oncol
13 Prostate cancer Complications radiotherapy and organ at risk bladder Urethra Rectum Anus penis testis prostate Radiotherapy prostate Complications acute General Lethargy local Skin reaction Intestinal discomfort/cramps Urge/incontinence Diarrhea/obstipation polyuria hematuria Rectal bleeding Late Increase stool freg/ Diarrhea Urge/Obstipation Blood/mucous loss Incontinence Polyuria/urge/pain Nacturia incontinence Erectile dysfunction 13
14 Prostate cancer Example of organ at risk for radiotherapy complications Musculus levator ani Musculus puborectalis Externe anale sphincter Interne anale sphincter Smeenk et al, Int J Radiat Oncol Biol Phys Step 1: predictive model fecal incontinence (mean anal wall dose) 25% Kans NTCP op complicatie 20% 15% 10% History of abdominal surgery No surgery 5% 0% Mean Gemiddelde dose anal dosis wall (Gy) (Gy) 50 14
15 Model-based approach 4 steps STEP 1: NTCP model Selection Multivariable NTCP-models, which patients have high risk op complications STEP 2: Individual dose comparison Dose reduction with protons? ( Dose): relevant DVH parameters STEP 3: Estimate NTCP reduction ( NTCP) Translate Dose to NTCP STEP 4: Validation and selection Validation External validation NTCP-model with new technology Langendijk, et al. Radiother Oncol 2013 Stap 2: Dose comparison Mean anus dose: Photons vs protons Photons Protons Mean anus dose 45 Gy Mean anus dose 27 Gy Van der Laan et al, Virtueel Protonen Centrum UMCG 15
16 Model-based approach 4 steps Selection STEP 1: NTCP model Multivariable NTCP-models, which patients have high risk op complications STEP 2: Individual dose comparison Dose reduction with protons? ( Dose): relevant DVH parameters STEP 3: Estimate NTCP reduction ( NTCP) Translate Dose to NTCP STEP 4: Validation and selection Validation External validation NTCP-model with new technology Langendijk, et al. Radiother Oncol 2013 Step 3: Risk reduction Plan comparison + predictive model 25% Kans NTCP op complicatie 20% 15% 10% Risk-reduction History of Surgery Fotonen (45 Gy) 5% 0% Dose-reduction Mean Gemiddelde dose anal dosis wall (Gy) (Gy) 50 Protonen (27 Gy) Van der Laan et al, Virtueel Protonen Centrum UMCG 16
17 Step 3: Risk reduction Plan comparison + predictive model 25% Kans Kans op op complicaties 20% 15% 10% 5% 0% Risicoverminderin g No surgery Dosisreductie Gemiddelde Gemiddelde dosis dosis anal(gy) wall (Gy) 50 Fotonen (45 Gy) Protonen (27 Gy) Van der Laan et al, Virtueel Protonen Centrum UMCG Step 2: Dose comparison Mean anus dose: Photons vs protons Photons Protons Mean dose anal wall 32 Gy Mean dose anal wall 22 Gy Van der Laan et al, Virtueel Protonen Centrum UMCG 17
18 Step 3: Risk reduction Plan comparison + predictive model 25% Kans Kans op op complicaties 20% 15% 10% 5% 0% Risicoverminderin g Dosisreductie History of surgery Gemiddelde Gemiddelde dosis dosis anal(gy) wall (Gy) 50 Fotonen (32 Gy) Protonen (20 Gy) Van der Laan et al, Virtueel Protonen Centrum UMCG Model-based approach 4 steps Selection STEP 1: NTCP model Multivariable NTCP-models, which patients have high risk op complications STEP 2: Individual dose comparison Dose reduction with protons? ( Dose): relevant DVH parameters STEP 3: Estimate NTCP reduction ( NTCP) Translate Dose to NTCP STEP 4: Validation and selection Validation External validation NTCP-model with new technology Langendijk, et al. Radiother Oncol
19 Numbers of patients with 6-month and 12-month toxicity and odds ratios (ORs) for patients receiving proton radiotherapy (PRT) and a matched intensity-modulated radiotherapy (IMRT Gray et al, Cancer 2013 Propensity Score Matched Rates of Additional Cancer Treatment for Patients Treated With Intensity- Modulated Radiation Therapy vs Proton Therapy 19
20 Patient reported outcomes after 3 dimensional conformal, intensity modulated, or proton beam radiotherapy for localized prostate cancer PT IMRT 3DCRT Cancer Volume 119, Issue 9, pages , 22 FEB 2013 DOI: /cncr The Model Based Approach How to trust models 20
21 Minimal requirements for high quality models Prospective data collection of toxicity Sufficient number of patients /events Multivariable analysis Clinical Decision Rule Formula, nomogram or graph Model performance Minimal requirements for high quality models Test generalizability External validation TRIPOD Type Type 4 Type 3 Type 2b Type 2a Type 1b Type 1a Description External validation of published High quality NTCP-model in separate dataset in other institution Development and external validation of High quality NTCP-model using one data set for development and a separate dataset for validation Non-random split-sample development and external validation Random split-sample development and validation Development and validation using resampling Development only Derived from: Collins, et al. Ann Int Med
22 What determines NTCP? Patient Disease Treatment Dose distribution Reserve capacity Substructure Organ at risk Risk factors Organ at risk NTCP Tissue damage Inflammation Radiobiological processes Repair Cell loss Fibrosis TOO MANY UNKNOWN DETAILS Model-based enrichment (RCT) Multivariable NTCP model Most relevant dose Volume factors Prospective data registration IMPT dose optimisation IMRT dose optimisation IMPT protons IMPT protons IMRT photons R IMRT photons Based on: Lambin, et al. Acta Oncol
23 Conclusions Bundle characteristic's of P are superior Always lower dose in OAR But, Not always translated in less toxicity for patients Selection is needed Model-based approach Personalized medicine Only patient with relevant advantage Cost effective Conclusions Proton RT is a technique in development. Expecting fast improvement Clinical validation Model-based approach is applicable as alternative for CRT. CRT is still needed for validation of dose escalation or hypofractionation with end point improvement tumor control. 23
Clinical Protontherapy Head and Neck cancer
Clinical Protontherapy Head and Neck cancer Coen Rasch Department of Radiation Oncology Academic Medical Center Amsterdam No disclosures 1 Introduction Proton vsphotonin the literature Model basedindicationprotocol
More informationAdvances in external beam radiotherapy
International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada
More informationProton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner
Proton Therapy: Where Are We Now and Where Are We Going? Erin Davis MSN, CRNP, ACNP BC Lead Nurse Practitioner Genevieve Hollis MSN, CRNP, ANP-BC, AOCN Oncology Nurse Practitioner Advanced Senior Lecturer-B
More informationSpecifics of treatment planning for active scanning and IMPT
Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,
More informationDosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer
Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer Tan Chek Wee 15 06 2016 National University Cancer Institute, Singapore Clinical Care Education Research
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationDiscuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons
Mark Pankuch, PhD Discuss the general planning concepts used in proton planning Review the unique handling of CTV / ITV / PTV when treating with protons Pencil Beam distributions and PBS optimization Cover
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationMeasurement of Dose to Critical Structures Surrounding the Prostate from. Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation Therapy (3D-CRT); A Comparative Study Erik
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationA TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM *
Romanian Reports in Physics, Vol. 66, No. 2, P. 394 400, 2014 A TREATMENT PLANNING STUDY COMPARING VMAT WITH 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER USING PINNACLE PLANNING SYSTEM * D. ADAM 1,2,
More informationFROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
More informationFuture Directions in Prostate Cancer: The Case for Protons. John J. Coen, MD Helen & Harry Gray Cancer Center
Future Directions in Prostate Cancer: The Case for Protons John J. Coen, MD Helen & Harry Gray Cancer Center November 14, 2012 Protons and prostate cancer Early proton experience at the MGH The case for
More informationRectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers
Rectal dose and toxicity dosimetric evaluation for various beam arrangements using pencil beam scanning protons with and without rectal spacers 2015 MAC-AAPM Annual Meeting, Baltimore, MD Heeteak Chung,
More informationVaginal Sparing with Volumetric Modulated Arc Therapy (VMAT) for Rectal Cancer. Scott Boulet BSc, RT(T)
Vaginal Sparing with Volumetric Modulated Arc Therapy (VMAT) for Rectal Cancer Scott Boulet BSc, RT(T) Outline Background Objectives Design Results Discussion Conclusion Acknowledgements Questions Background
More informationIMPT with Carbon Ions
IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de
More informationRadiation protection in proton therapy
Radiation protection in proton therapy Pieternel van der Tol Medical Physicist - HollandPTC pvandertol@hollandptc.nl Marjan Dwarswaard René Bolt Marc-Jan van Goethem Lars Murrer Outline Introduction Interactions
More informationIMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia
IMRT - the physician s eye-view Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia The goals of cancer therapy Local control Survival Functional status Quality of life Causes
More informationEvaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy
Evaluation of Normal Tissue Complication Probability and Risk of Second Primary Cancer in Prostate Radiotherapy Rungdham Takam Thesis submitted for the degree of Doctor of Philosophy in The School of Chemistry
More informationProstate Cancer. 3DCRT vs IMRT : Hasan Murshed
Prostate Cancer 3DCRT vs IMRT : the second debate Hasan Murshed Take home message IMRT allows dose escalation. Preliminary data shows IMRT technique improves cancer control while keeping acceptable morbidity
More informationBiological Optimization of Hadrontherapy. Uwe Oelfke
4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General
More informationProton Therapy for Prostate Cancer. Andrew K. Lee, MD, MPH Director Proton Therapy Center
Proton Therapy for Prostate Cancer Andrew K. Lee, MD, MPH Director Proton Therapy Center Disclosures No relevant financial disclosures This presentation will not discuss off-label or investigational treatments
More informationIMAT: intensity-modulated arc therapy
: intensity-modulated arc therapy M. Iori S. Maria Nuova Hospital, Medical Physics Department Reggio Emilia, Italy 1 Topics of the talk Rotational IMRT techniques: modalities & dedicated inverse-planning
More informationRadiotherapy and Oncology
Radiotherapy and Oncology 98 (2011) 74 80 Contents lists available at ScienceDirect Radiotherapy and Oncology journal homepage: www.thegreenjournal.com Prostate treatment planning Helical tomotherapy and
More informationTreatment Planning (Protons vs. Photons)
Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield
More informationA Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer
A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer Tony Kin Ming Lam Radiation Planner Dr Patricia Lindsay, Radiation Physicist Dr John Kim, Radiation Oncologist Dr Kim Ann Ung,
More informationDepartment of Radiotherapy & Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt.
Original article Res. Oncol. Vol. 12, No. 1, Jun. 2016:10-14 Dosimetric comparison of 3D conformal conventional radiotherapy versus intensity-modulated radiation therapy both in conventional and high dose
More informationDisclosures. Proton therapy advantages. Why are comparing therapies difficult? Proton Therapy for Low Risk Prostate Cancer
Proton Therapy for Low Risk Prostate Cancer Disclosures No relevant financial disclosures This presentation will not discuss off-label or investigational treatments Andrew K. Lee, MD, MPH Associate Professor
More informationOPTIMIZATION OF COLLIMATOR PARAMETERS TO REDUCE RECTAL DOSE IN INTENSITY-MODULATED PROSTATE TREATMENT PLANNING
Medical Dosimetry, Vol. 30, No. 4, pp. 205-212, 2005 Copyright 2005 American Association of Medical Dosimetrists Printed in the USA. All rights reserved 0958-3947/05/$ see front matter doi:10.1016/j.meddos.2005.06.002
More informationState-of-the-art proton therapy: The physicist s perspective
State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New
More informationProton Stereotactic Radiotherapy: Clinical Overview. Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS
Proton Stereotactic Radiotherapy: Clinical Overview Brian Winey, Ph.D. Physicist, MGH Assistant Professor, HMS Acknowledgements Radiation Oncologists and Physicists at various institutions (MGH, MDACC,
More informationClinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate
Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Reference: NHS England B01X09 First published: March 2016 Prepared by NHS England Specialised Services Clinical
More informationFeasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment
Chinese Journal of Cancer Original Article Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment Suresh Rana 1 and ChihYao Cheng 2 Abstract The volumetric modulated
More informationCharacterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca
More informationImpact of Contouring Variability on Dose- Volume Metrics used in Treatment Plan Optimization of Prostate IMRT
Open Access Original Article DOI: 10.7759/cureus.144 Impact of Contouring Variability on Dose- Volume Metrics used in Treatment Plan Optimization of Prostate IMRT Arvand Barghi, Carol Johnson 2, Andrew
More informationStereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors
Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors Anna Bruynzeel, Radiation Oncologist VU University Medical Center, Amsterdam, The Netherlands Current standard
More informationLa Pianificazione e I Volumi di Trattamento
TRATTAMENTI INTEGRATI NEL CARCINOMA DELLA VULVA La Pianificazione e I Volumi di Trattamento PAOLO MUTO Direttore UOC Radioterapia ISTITUTO NAZIONALE TUMORI IRCCS Fondazione Pascale di Napoli Minimize collateral
More informationRadiation Therapy: From Fallacy to Science
27 th Annual Management of Colon and Rectal Diseases 2.23.2019 Radiation Therapy: From Fallacy to Science Hadi Zahra, MD, DABR Radiation Oncologist CHI Health Henry Lynch Cancer Center Assistant Clinical
More informationRadiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.
Radiation Related Second Cancers Stephen F. Kry, Ph.D., D.ABR. Objectives Radiation is a well known carcinogen Atomic bomb survivors Accidental exposure Occupational exposure Medically exposed Radiotherapy
More informationOverview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS
IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS Heng Li, PhD Assistant Professor, Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX, 773
More informationGuidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy
Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy VERSION 2.1 April 2015 Table of Contents Abbreviations & Glossary... 3 Executive Summary...
More informationTHE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS
THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS ICTP SCHOOL ON MEDICAL PHYSICS FOR RADIATION THERAPY DOSIMETRY AND TREATMENT PLANNING FOR BASIC AND ADVANCED APPLICATIONS March
More informationNew Technologies for the Radiotherapy of Prostate Cancer
Prostate Cancer Meyer JL (ed): IMRT, IGRT, SBRT Advances in the Treatment Planning and Delivery of Radiotherapy. Front Radiat Ther Oncol. Basel, Karger, 27, vol. 4, pp 315 337 New Technologies for the
More informationProstate Cancer Treatments. Hasan Murshed, MD., DABR Radiation Oncology Residency, UAB Fellowship, MDACC Board Certified, ABR
Prostate Cancer Treatments Hasan Murshed, MD., DABR Radiation Oncology Residency, UAB Fellowship, MDACC Board Certified, ABR A Brief History of Radiation Wilhelm Roentgen discovered X- rays on November
More informationA Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population
A Dosimetric Comparison of Whole-Lung Treatment Techniques in the Pediatric Population Corresponding Author: Christina L. Bosarge, B.S., R.T. (R) (T) Indiana University School of Medicine Department of
More information3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis
Iran. J. Radiat. Res., 2007; 5 (1): 1-8 3-Dimensional conformal radiotherapy versus intensity modulated radiotherapy for localized prostate cancer: Dosimetric and radiobiologic analysis A.K. Bhardwaj 1*,T.S.
More informationPotential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana
University of Groningen Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's
More informationProton beam therapy for prostate cancer. 1. What is the clinical effectiveness of proton beam therapy in the treatment of prostate cancer?
QUESTION(S) TO BE ADDRESSED Proton beam therapy for prostate cancer 1. What is the clinical effectiveness of proton beam therapy in the treatment of prostate cancer? 2. What is the cost effectiveness of
More informationParticle (proton) Therapy Randomized trials vs. Prospective registry. Andrew K. Lee, MD, MPH Associate Professor Department of Radiation Oncology
Particle (proton) Therapy Randomized trials vs. Prospective registry Andrew K. Lee, MD, MPH Associate Professor Department of Radiation Oncology Should we do randomized trials? Are randomized trials needed
More informationOverview of Clinical and Research Activities at Georgetown University Hospital
Overview of Clinical and Research Activities at Georgetown University Hospital Dalong Pang, Ph.D. Department of Radiation Medicine Georgetown University Hospital Clinical Operation Two Varian linear accelerators
More informationSarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington
Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation
More informationFrom position verification and correction to adaptive RT Adaptive RT and dose accumulation
From position verification and correction to adaptive RT Adaptive RT and dose accumulation Hans de Boer Move away from Single pre-treatment scan Single treatment plan Treatment corrections by couch shifts
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 6, 2015 Determination of optimal PTV margin for patients receiving CBCT-guided prostate IMRT: comparative analysis based on CBCT dose calculation
More informationRadiotherapy for Rectal Cancer. Kevin Palumbo Adelaide Radiotherapy Centre
Radiotherapy for Rectal Cancer Kevin Palumbo Adelaide Radiotherapy Centre Overview CRC are common (3 rd commonest cancer) rectal Ca approx 25-30% of all CRC. Presentation PR bleeding: beware attributing
More informationProton beam therapy: the hope and the hype
Proton beam therapy: the hope and the hype Professor Karol Sikora Chief Medical Officer Proton Partners International WelshConfed18 Protons The hope and the hype Professor Karol Sikora Chief Medical Officer
More informationEfficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO
Investigations and research Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO M. Kunze-Busch P. van Kollenburg Department of Radiation Oncology, Radboud University Nijmegen Medical
More informationAccuracy Requirements and Uncertainty Considerations in Radiation Therapy
Departments of Oncology and Medical Biophysics Accuracy Requirements and Uncertainty Considerations in Radiation Therapy Introduction and Overview 6 August 2013 Jacob (Jake) Van Dyk Conformality 18 16
More informationIMRT RTOG Definitive IMRT for Low Risk Prostate Cancer. All about dose and dose matters, probably Although hormones may matter
Definitive for Low Risk Prostate Cancer Howard Sandler, MD, MS Bloom Family Chair in Cancer Therapeutics Cedar-Sinai Medical Center All about dose and dose matters, probably Although hormones may matter
More informationA dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas Reid F. Thompson University of Pennsylvania, Philadelphia, Pennsylvania 1914 Sonal U. Mayekar Thomas
More informationHypofractionation for Prostate Cancer: the Present Luca Incrocci, MD PhD
Hypofractionation for Prostate Cancer: the Present Luca Incrocci, MD PhD Professor of Genito-Urinary Radiotherapy Erasmus MC Cancer Institute Rotterdam, The Netherlands Themadag Prostaatcarcinoom 15 maart
More informationClinical Education A comprehensive and specific training program. carry out effective treatments from day one
Proton Therapy Clinical Education A comprehensive and specific training program carry out effective treatments from day one Forewarned is forearmed Although over 100,000 patients have been treated in proton
More informationART for Cervical Cancer: Dosimetry and Technical Aspects
ART for Cervical Cancer: Dosimetry and Technical Aspects D.A. Jaffray, Ph.D. Radiation Therapy Physics Princess Margaret Cancer Centre/Techna/Ontario Cancer Institute Professor Departments of Radiation
More informationTreatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 4, FALL 2006 Treatment of exceptionally large prostate cancer patients with low-energy intensity-modulated photons Mei Sun and Lijun Ma a University
More informationIMRT Planning Basics AAMD Student Webinar
IMRT Planning Basics AAMD Student Webinar March 12, 2014 Karen Chin Snyder, MS Senior Associate Physicist Department of Radiation Oncology Disclosures The presenter has received speaker honoraria from
More informationLeila E. A. Nichol Royal Surrey County Hospital
2 nd UK and Ireland Dosimetry Check User Meeting Symposium Clatterbridge Cancer Centre, 24 th October 2012 Leila E. A. Nichol Royal Surrey County Hospital Leila.Nichol@nhs.net *My experience with Dosimetry
More information8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions
Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation
More informationNovel techniques for normal tissue toxicity modelling. Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy
Novel techniques for normal tissue toxicity modelling Laura Cella Institute of Biostructures and Bioimaging National Research Council of Italy Disclosure: I have no conflict of interest An honorarium is
More informationThe sigmoid colon and bladder shielding in whole pelvic irradiation at prostate cancer (forward planned IMRT from Institute of Oncology Ljubljana)
doi:10.2478/v10019-009-0001-4 research article The sigmoid colon and bladder shielding in whole pelvic irradiation at prostate cancer (forward planned IMRT from Institute of Oncology Ljubljana) Daša Grabec
More informationRole of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation
Role of Belly Board Device in the Age of Intensity Modulated Radiotherapy for Pelvic Irradiation 2017 AAMD 42 nd Annual Meeting Neil C. Estabrook, MD 6 / 14 / 2017 7/5/2017 1 Conflicts of Interest None
More informationInnovazioni tecnologiche in Radioterapia" Sergio Fersino Radioterapia Oncologica
Innovazioni tecnologiche in Radioterapia" Sergio Fersino Radioterapia Oncologica 2014 HYPOFRACTIONATION & PROSTATE CANCER HYPOFRACTIONATION & PROSTATE CANCER: TECHNOLOGY: HIGH CONFORMAL DOSE & IMAGING
More informationHampton University Proton Therapy Institute
Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI
More informationDemands and Perspectives of Hadron Therapy
Demands and Perspectives of Hadron Therapy Alexander Lin, M.D. Assistant Professor University of Pennsylvania Direction of Operations Roberts Proton Therapy Center Disclosures Teva Pharmaceuticals: Advisory
More informationConsiderations when treating lung cancer with passive scatter or active scanning proton therapy
Mini-Review Considerations when treating lung cancer with passive scatter or active scanning proton therapy Sara St. James, Clemens Grassberger, Hsiao-Ming Lu Department of Radiation Oncology, Massachusetts
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference Jean-Marc BOTHY - CSO June 8, 2017 2017 IBA SA Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth drivers;
More informationImplementation of Hybrid IMRT Breast Planning
Implementation of Hybrid IMRT Breast Planning Dianne Kearns, Richard Ferguson & Suzanne Smith Dosimetrist Manager Department of Clinical Physics and Bio-Engineering, NHS Greater Glasgow & Clyde Summary
More information...some UK and Australian hadron therapy initiatives...
Particles for patients, Radiotherapy with protons (and other ions): potential, problems and $$$s...some UK and Australian hadron therapy initiatives... David Thwaites Institute of Medical Physics Context
More informationJOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016 Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily
More informationThe role of chemoradiotherapy in GE junction and gastric cancer. Karin Haustermans
The role of chemoradiotherapy in GE junction and gastric cancer Karin Haustermans Overview Postoperative chemoradiotherapy Preoperative chemoradiotherapy Palliative radiation Technical aspects Overview
More informationDosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles
Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 2017 Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for
More informationFuture upcoming technologies and what audit needs to address
Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple
More informationIt s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018
It s All About Margins Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018 Why margins? The smaller the better! Short Introduction Erasmus MC has been using the CyberKnife Robotic Radiosurgery System
More informationPredictive Models of Toxicity in External Radiotherapy
Predictive Models of Toxicity in External Radiotherapy Dosimetric Issues* Claudio Fiorino, PhD 1 ; Tiziana Rancati, PhD 2 ; and Riccardo Valdagni, MD 2 Dose-volume modeling of late and acute toxicity in
More informationTreatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases
Tran et al. Radiation Oncology (2017) 12:10 DOI 10.1186/s13014-016-0761-0 RESEARCH Open Access Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases Angelia Tran 1, Jingjing
More informationUCL. Rectum Adenocarcinoma. Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans
Rectum Adenocarcinoma Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans Fifth Belgian Surgical Week May 6th, 2004, Oostende SOR rectum adenocarcinoma Indication of radiotherapy
More informationRadiotherapy Advances
Radiotherapy Advances Not Radiotherapy Principles IMRT IGRT Image Fusion Planning Introduction IMRT = Intensity Modulated RadioTherapy Restriction: IMRT with photon beams IMRT: Highly conformal technique
More informationPresent status and future of Proton beam therapy
Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer
More informationRole of IMRT in the Treatment of Gynecologic Malignancies. John C. Roeske, PhD Associate Professor The University of Chicago
Role of IMRT in the Treatment of Gynecologic Malignancies John C. Roeske, PhD Associate Professor The University of Chicago Acknowledgements B Aydogan, PhD Univ of Chicago P Chan, MD Princess Margaret
More informationProton Beam Therapy Luxury OR Necessity?
Proton Beam Therapy Luxury OR Necessity? Jeffrey Tuan, FRCR Senior Consultant & Research Director Radiation Oncology, National Cancer Centre Singapore Adj Asst Professor Oncology ACP Duke-NUS Medical School
More informationImage Guided Proton Therapy and Treatment Adaptation
Image Guided Proton Therapy and Treatment Adaptation www.hollandptc.nl d.r.schaart@tudelft.nl Cancer in The Netherlands About 1 in 3 people get cancer in some stage of their life 86.800 new cancer patients
More informationREVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria
REVISITING ICRU VOLUME DEFINITIONS Eduardo Rosenblatt Vienna, Austria Objective: To introduce target volumes and organ at risk concepts as defined by ICRU. 3D-CRT is the standard There was a need for a
More informationRadiotherapy Physics. Overview of lectures 16/01/2018. Dr Simon Thomas.
Radiotherapy Physics Dr Simon Thomas. Innovation and excellence in health and care Addenbrooke s Hospital I Rosie Hospital Overview of lectures What is Radiotherapy? Example of problem to be solved prostate
More informationCitation for published version (APA): Laan, H. P. V. D. (2010). Optimising CT guided radiotherapy for breast cancer Groningen: s.n.
University of Groningen Optimising CT guided radiotherapy for breast cancer Laan, Hans Paul van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationOriginal Article. Teyyiba Kanwal, Muhammad Khalid, Syed Ijaz Hussain Shah, Khawar Nadeem
Original Article Treatment Planning Evaluation of Sliding Window and Multiple Static Segments Technique in Intensity Modulated Radiotherapy for Different Beam Directions Teyyiba Kanwal, Muhammad Khalid,
More informationTreatment Planning & IGRT Credentialing for NRG SBRT Trials
Treatment Planning & IGRT Credentialing for NRG SBRT Trials Hania Al Hallaq, Ph.D. Department of Radiation & Cellular Oncology The University of Chicago Learning Objectives Explain rationale behind credentialing
More informationEstimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy
U N I V E R S I T Y O F B E R G E N Estimated risk of radiation-induced lung cancer in paediatric patients following electron, photon and proton therapy Camilla H Stokkevåg 1, Grete-May Engeseth 1, Kristian
More informationEvaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients
Evaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients Aliaa Mahmoud (1,4), Ehab M. Attalla (2,3), M..S. El-Nagdy (4), Gihan Kamel (4) (1) Radiation
More information> 80%), < -1), , 0.05). 63.6% 13.7% 7.2% ( (95% CI)
GANDER REVIEW Mid- to Long-term Results of Total Disc Replacement: A Prospective Analysis with 5- to 10-Year Follow-Up The Spine Journal Volume 14m Number 8 Christopher J. Siepe, Franziska Heider, Karsten
More informationIGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose
IGRT Protocol Design and Informed Margins DJ Vile, PhD Conflict of Interest I have no conflict of interest to disclose Outline Overview and definitions Quantification of motion Influences on margin selection
More informationStatistical Analysis and Volumetric Dose for Organ at Risk of Prostate Cancer
The African Review of Physics (2013) 8:0063 477 Statistical Analysis and Volumetric Dose for Organ at Risk of Prostate Cancer F. Assaoui¹,*, A. Bazine² and T. Kebdani³ ¹ Medical Physics Unit, Radiotherapy
More informationJeong-Eun Rah 1, Gwe-Ya Kim 2, Do Hoon Oh 1, Tae Hyun Kim 3, Jong Won Kim 4, Dae Yong Kim 3, Sung Yong Park 5 and Dongho Shin 3*
Rah et al. Radiation Oncology (2016) 11:140 DOI 10.1186/s13014-016-0717-4 RESEARCH Open Access A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation
More information